Validation of the Prognostic Utility of ESTRO/EORTC Oligometastatic Disease Classification: A Secondary Analysis From the Population-Based Phase II SABR-5 Trial.
Int J Radiat Oncol Biol Phys
; 114(5): 849-855, 2022 12 01.
Article
in En
| MEDLINE
| ID: mdl-36302495
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Radiosurgery
/
Neoplasms
Type of study:
Observational_studies
/
Prognostic_studies
Aspects:
Patient_preference
Limits:
Adolescent
/
Adult
/
Humans
Country/Region as subject:
America do norte
Language:
En
Journal:
Int J Radiat Oncol Biol Phys
Year:
2022
Document type:
Article
Affiliation country:
Country of publication: